EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Luteolin on Cancer

Melisa Çetinkaya iD, Yusuf Baran

Vaccines · 27.02.2023 · 11 (3) · 554

DOI: 10.3390/vaccines11030554 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 27.02.2023. Verfasst von Melisa Çetinkaya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, İzmir Institute of Technology, İzmir 35430, Turkey. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a global concern, as the rate of incidence is increasing each year. The challenges related to the current chemotherapy drugs, such as the concerns related to toxicity, turn to cancer therapeutic research to discover alternative therapy strategies that are less toxic to normal cells. Among those studies, the use of flavonoids—natural compounds produced by plants as secondary metabolites for cancer therapy—has been a hot topic in cancer treatment. Luteolin, a flavonoid that has been present in many fruits, vegetables, and herbs, has been identified to exhibit numerous biological activities, including anti-inflammatory, antidiabetic, and anticancer properties. The anticancer property of Luteolin has been extensively researched in many cancer types and has been related to its ability to inhibit tumor growth by targeting cellular processes such as apoptosis, angiogenesis, migration, and cell cycle progression. It achieves this by interacting with various signaling pathways and proteins. In the current review, the molecular targets of Luteolin as it exerts its anticancer properties, the combination therapy that includes Luteolin with other flavonoids or chemotherapeutic drugs, and the nanodelivery strategies for Luteolin are described for several cancer types.

Schlagwörter

Stichwörter der Autor:innen

Luteolinangiogenesisanticancerapoptosiscell cycle regulationcombination therapyflavonoidsmetastasismiRNAsnanodelivery systems

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Faculty of Science, İzmir Institute of Technology, İzmir 35430, Turkey.

ORCID-Profile: Melisa Çetinkaya

Zitieren

APA

Çetinkaya, M., & Baran, Y. (2023). Therapeutic Potential of Luteolin on Cancer. Vaccines, 11(3), 554. https://doi.org/10.3390/vaccines11030554

Vancouver

Çetinkaya M, Baran Y. Therapeutic Potential of Luteolin on Cancer. Vaccines. 2023;11(3):554. doi:10.3390/vaccines11030554

BibTeX
@article{etinkaya2023,
  author = {Çetinkaya, Melisa and Baran, Yusuf},
  title = {Therapeutic Potential of Luteolin on Cancer},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {3},
  pages = {554},
  doi = {10.3390/vaccines11030554}
}
Kostenlos starten →